PDL BioPharma, Inc. PDLI

Other  —  Other
Market cap
—
P/E
0.0×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
P/E ratio
5.72 3.99 0.00 0.00 —
P/S ratio
1.50 1.39 2.13 7.04 —
P/FCF ratio
3.18 3.04 5.80 5.49 —
P/Operating CF
23.34 (25.57) (204.47) (20.14) —
P/B ratio
0.48 0.53 0.58 0.65 —
EV/Sales
1.46 0.10 0.77 4.45 —
EV/EBITDA
2.35 0.13 0.00 0.00 —
EV/FCF
3.10 0.21 2.09 3.47 —
Current Ratio
3.05 3.32 9.86 6.87 —
Net Debt/EBITDA
(0.06) (1.79) 11.51 2.02 —
Debt/Equity
0.31 0.14 0.17 0.05 —
ROE
8.76% 13.83% (8.74%) (10.64%) —
ROA
5.71% 9.01% (6.24%) (8.38%) 0.00%
ROIC
10.85% 28.09% (6.88%) (14.61%) —
Return on Tangible Assets
23.76% 24.36% (14.58%) (25.72%) —
Average Days of Receivables
59.94 35.56 39.88 90.34 —
Earnings Yield
17.49% 25.09% (15.52%) (19.38%) —
Free Cash Flow Yield
31.42% 32.87% 17.25% 18.23% —
Free Cash Flow per Share
0.70 0.94 0.27 0.42 —
Book value per Share
4.61 5.44 5.01 5.00 —
Free Cash Flow
114.78 146.58 40.02 49.37 —
EV/EBIT
2.75 0.16 0.00 0.00 —
Other line items

Show all line items

Columns are period end dates